Instrument firm executives at the Pittsburgh Conference on Analytical Chemistry & Applied Spectroscopy (Pittcon) this week said they want to see last year’s healthy sales pace continue into 2015.
Recent Media Coverage
Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.
PerkinElmer (Massachussetts, USA) has announced that they will collaborate with Waters Corporation (Massachussetts, USA) to standardize PerkinElmer liquid chromatography (LC) and gas chromatography (GC) instrumention.
Lab solutions provider PerkinElmer Inc. announced its collaboration with Johnson & Johnson Innovation to equip its JLABS @South San Francisco (JLABS @SSF) life science incubator with instruments and lab services to address the research needs of resident startups.
PerkinElmer Inc., a global leader focused on improving the health and safety of people and the environment, has announced the launch of its Adulterant Screen software.
Lab automation systems are used in R&D laboratories for a wide range of operational applications and purposes.
Operating in over 150 countries, PerkinElmer is one of the global companies listed on the S&P 500 and the Russell 3000 Indices.
An interview with Morey Kraus, Chief Scientific Officer of the Diagnostics division of PerkinElmer, and Kypros Nicolaides, Professor of Fetal Medicine, King's College, London, UK.
Scientific instruments maker PerkinElmer Inc on Thursday reported better-than-expected fourth quarter revenue and profit, helped by strong demand for its newborn screening tests in developing markets.
This new facility provides a comprehensive offering of lab services to hospitals and patients in China, supporting the prevention of birth defects in newborns and infectious disease in adults.
Food fraud is defined by the United Kingdom’s Food Standard Agency as date tampering or selling goods past their use-by date, packing and selling products with an unknown origin, deliberately mislabeling food like farmed salmon as being wild, or using stolen or poached animal meat.
Severe Combined Immunodeficiency (SCID) is a group of disorders caused by defects in genes involved in the development and function of T-cells and other infection-fighting immune cells.
During biosimilar development, it is necessary to demonstrate that the physicochemical properties, efficacy, and safety (e.g., immunogenicity) of the biosimilar are similar to those of the targeted branded biologic.
Robert Roe investigates cloud and SaaS deployment models and the inherent flexibility and scalability they provide to users.
US-based PerkinElmer, Inc. (NYSE: PKI) has completed its acquisition of Sweden-based analytical instruments supplier Perten Instruments Group AB. The deal is worth around USD 266m. Perten supplies instruments for quality control of food, grain, flour and feed.
OncoSec Medical Inc, San Diego, a company developing DNA-based intratumoral cancer immunotherapies, recently announced a collaboration with PerkinElmer Inc and the University of California, Los Angeles (UCLA), to help researchers develop biomarker tests for evaluating a patient’s immune response to cancer.
PerkinElmer has acquired Perten Instruments for $266m to ‘significantly expand’ its presence in the food testing.
PerkinElmer Inc. (PKI) on Thursday reported third-quarter profit of $42.3 million. The results met Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was also for earnings of 57 cents per share.